ALPS Medical Breakthroughs ETF (SBIO)

Add to Watchlists
Create an Alert
32.43 -0.05  -0.14% NYSE Arca Dec 11, 20:00 Delayed 2m USD
View Full Chart
SBIO Price Chart
View All SBIO News

SBIO News

SBIO Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 6.85% 6.63% 2.13% 1
3M 4.05% 3.91% 0.19% 12
6M 26.10% 25.55% 7.91% 3
YTD 41.51% 40.99% 23.41% 6
1Y 36.73% 36.23% 23.27% 7
3Y -- -- 5.61% --
5Y -- -- 17.04% --
10Y -- -- 11.49% --
As of Dec. 11, 2017. Returns for periods of 1 year and above are annualized.

SBIO Asset Allocation

Type % Net % Long % Short
Cash 0.02% 0.03% 0.00%
Stock 99.97% 99.97% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00% 0.00% 0.00
As of Nov. 30, 2017

SBIO Region Exposure

Americas 88.55%
North America 88.55%
Latin America 0.00
Greater Europe 11.45%
United Kingdom 2.85%
Europe Developed 8.26%
Europe Emerging 0.00
Africa/Middle East 0.35%
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of Nov. 30, 2017. Region breakdown data is calculated by using the long position holdings of the portfolio.

SBIO Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of Nov. 30, 2017

SBIO Stock Market Capitalization

Giant 0.00
Large 0.00
Medium 25.59%
Small 54.59%
Micro 19.82%
As of Nov. 30, 2017

SBIO Stock Style Exposure

Large Cap Value 0.00
Large Cap Blend 0.00
Large Cap Growth 0.00
Mid Cap Value 0.00
Mid Cap Blend 10.00%
Mid Cap Growth 16.50%
Small Cap Value 5.20%
Small Cap Blend 11.29%
Small Cap Growth 57.00%
As of Nov. 30, 2017
View More Holdings

SBIO Top 10 Holdings

Symbol Name % Weight Price % Chg
NKTR Nektar Therapeutics Inc 6.03% 55.21 +2.30%
BLUE bluebird bio Inc 5.64% 197.75 -2.01%
EXEL Exelixis Inc 4.70% 26.42 +0.00%
GLPG Galapagos NV ADR 3.37% 88.01 -1.66%
TARO Taro Pharmaceutical Industries Ltd 3.32% 104.91 +0.28%
AKRX Akorn Inc 3.17% 32.64 -0.85%
BGNE BeiGene Ltd ADR 3.05% 91.39 -4.78%
ACAD ACADIA Pharmaceuticals Inc 2.82% 31.01 +3.47%
AAAP Advanced Accelerator Applications SA ADR 2.78% -- --
FGEN FibroGen Inc 2.76% 45.05 -2.91%
As of Nov. 30, 2017
Advertisement

SBIO One Page Reports

SBIO Basic Info

Style
Equity Style Small Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name ALPS
Benchmark Index
Poliwogg Medical Breakthroughs TR USD
100.0%

SBIO Manager Info

Name Tenure
Andrew Hicks 1.59 yrs
Michael Akins 2.84 yrs
Ryan Mischker 2.59 yrs

SBIO Net Fund Flows

1M -3.170M
3M -1.565M
6M -4.720M
YTD -8.385M
1Y -21.01M
3Y 150.89M
5Y --
10Y --
As of Nov. 30, 2017

SBIO Risk Info

Beta (5Y) --
Max Drawdown (All) 49.69%
Historical Sharpe (10Y) --
Historical Sortino (All) 0.6243
30-Day Rolling Volatility 21.63%
Daily Value at Risk (VaR) 1% (All) 6.48%
Monthly Value at Risk (VaR) 1% (All) 26.90%

SBIO Fundamentals

Dividend Yield TTM (12-11-17) 0.00
SEC Yield (11-30-17) -0.50%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 6.721
Weighted Average Price to Book Ratio 4.477
Weighted Median ROE -26.97%
Weighted Median ROA -24.42%
Forecasted Dividend Yield 0.01%
Forecasted PE Ratio 24.03
Forecasted Price to Sales Ratio 4.062
Forecasted Price to Book Ratio 2.192
Number of Holdings 91
As of Nov. 30, 2017

SBIO Growth Estimates

Forecasted 5 Yr Earnings Growth 21.22%
Forecasted Book Value Growth 16.83%
Forecasted Cash Flow Growth 33.64%
Forecasted Earnings Growth -5.00%
Forecasted Revenue Growth 14.05%
As of Nov. 30, 2017

SBIO Comparables

Edit

SBIO Attributes

Key Dates
Inception Date 12/30/2014
Last Annual Report Date 11/30/2016
Last Prospectus Date 3/31/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

SBIO Excel Add-In Codes

  • Name: =YCI("SBIO","name")
  • Broad Asset Class: =YCI("SBIO", "broad_asset_class")
  • Broad Category: =YCI("SBIO", "broad_category_group")
  • Prospectus Objective: =YCI("SBIO", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.